Condition
Amblyopia Unilateral
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Not Yet Recruiting1
Active Not Recruiting1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07226141Phase 1Not Yet Recruiting
Valproate for the Treatment of Residual Amblyopia
NCT06498206Not ApplicableRecruitingPrimary
AR Training Versus Patching in Unilateral Amblyopia
NCT06704737Not ApplicableActive Not RecruitingPrimary
AR Training in Adults With Unilateral Amblyopia
Showing all 3 trials